Revolutionary mRNA vaccines made by Chinese firms will be ready to hit market by end of year, says industry chief

• Made in China jabs using genetic technology could soon be available, while BioNTech’s Chinese partner is seeking approval to use the vaccine on the mainland
• The drugs that use messenger RNA to stimulate the immune system reported high efficacy rates following clinical trials